| 1 | Dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4,
KCNC3,
KCND2,
KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 4 4, 13 |
| 2 | Daraprim | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 2件: 2 2, 4 |
| 3 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 |
| 4 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A,
ADRA2B,
ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 |
| 5 | ESKETAMINE | 1件: Esketamine Esketamine | 1件: D07283
D07283
| 5件: GRIN1 GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 4, 70 |
| 6 | Ketanest | - | - | - | - | 3件: 2 2, 4, 70 |
| 7 | Ketanest-S | - | - | - | - | 3件: 2 2, 4, 70 |
| 8 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 |
| 9 | PYRIMETHAMINE | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 4件: 2 2, 4, 19, 65 |
| 10 | Stem Cells | - | - | - | - | 5件: 2 2, 4, 46, 96, 113 |